Rectal vs. sublingual misoprostol in cesarean section: three‑arm, randomized clinical trial

• Main Authors: Fatemeh Zahra Bagheri (Author), Mahboobeh Azadehrah (Author), Bizhan Shabankhani (Author), Hooshang Akbari (Author), Ebrahim Nasiri Ferami (Author)
• Format: Book
• Published: Babol University of Medical Sciences, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Misoprostol is a myometrial stimulant with uterotonic properties and can be administered rectally, vaginally, or sublingually. Numerous studies have investigated the effect of misoprostol on the prevention and treatment of PPH (postpartum hemorrhage) after vaginal delivery, but its use t...